517 related articles for article (PubMed ID: 21353101)
1. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review.
Olvey EL; Armstrong EP; Grizzle AJ
Clin Ther; 2010 Dec; 32(14):2282-303. PubMed ID: 21353101
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial.
Brashear A; McAfee AL; Kuhn ER; Fyffe J
Arch Phys Med Rehabil; 2004 May; 85(5):705-9. PubMed ID: 15129392
[TBL] [Abstract][Full Text] [Related]
3. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.
Demetrios M; Khan F; Turner-Stokes L; Brand C; McSweeney S
Cochrane Database Syst Rev; 2013 Jun; (6):CD009689. PubMed ID: 23740539
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.
Cardoso E; Rodrigues B; Lucena R; Oliveira IR; Pedreira G; Melo A
Arq Neuropsiquiatr; 2005 Mar; 63(1):30-3. PubMed ID: 15830061
[TBL] [Abstract][Full Text] [Related]
5. What's the "catch" in upper-limb post-stroke spasticity: expanding the role of botulinum toxin applications.
Rosales RL; Kanovsky P; Fernandez HH
Parkinsonism Relat Disord; 2011 Nov; 17 Suppl 1():S3-10. PubMed ID: 21999894
[TBL] [Abstract][Full Text] [Related]
6. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
Dong Y; Wu T; Hu X; Wang T
Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
[TBL] [Abstract][Full Text] [Related]
8. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
[TBL] [Abstract][Full Text] [Related]
9. Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials.
Jia S; Liu Y; Shen L; Liang X; Xu X; Wei Y
J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104682. PubMed ID: 32305277
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Botulinum Toxin for Lower Limbs Spasticity after Stroke: A Systematic Review and Meta-Analysis.
Wu T; Li JH; Song HX; Dong Y
Top Stroke Rehabil; 2016 Jun; 23(3):217-23. PubMed ID: 27077980
[TBL] [Abstract][Full Text] [Related]
11. Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: a systematic review of the literature.
van Kuijk AA; Geurts AC; Bevaart BJ; van Limbeek J
J Rehabil Med; 2002 Mar; 34(2):51-61. PubMed ID: 12019580
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
Buyukavci R; Akturk S; Ersoy Y
Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of upper-limb function measurement methods in botulinum toxin intervention for focal spasticity.
Ashford S; Turner-Stokes L
Physiother Res Int; 2013 Sep; 18(3):178-89. PubMed ID: 23630050
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin in poststroke spasticity.
Ozcakir S; Sivrioglu K
Clin Med Res; 2007 Jun; 5(2):132-8. PubMed ID: 17607049
[TBL] [Abstract][Full Text] [Related]
15. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
Pullman SL; Greene P; Fahn S; Pedersen SF
Arch Neurol; 1996 Jul; 53(7):617-24. PubMed ID: 8929169
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
Sheean G
Drug Saf; 2006; 29(1):31-48. PubMed ID: 16454533
[TBL] [Abstract][Full Text] [Related]
17. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.
Turkel CC; Bowen B; Liu J; Brin MF
Arch Phys Med Rehabil; 2006 Jun; 87(6):786-92. PubMed ID: 16731213
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke.
Santamato A; Panza F; Ranieri M; Frisardi V; Micello MF; Filoni S; Fortunato F; Intiso D; Basciani M; Logroscino G; Fiore P
J Neural Transm (Vienna); 2013 Mar; 120(3):469-76. PubMed ID: 22955957
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacology and upper limb poststroke spasticity: a review. International Society of Prosthetics and Orthotics].
Yelnik AP
Ann Readapt Med Phys; 2004 Oct; 47(8):575-89. PubMed ID: 15465163
[TBL] [Abstract][Full Text] [Related]
20. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study.
Simpson DM; Gracies JM; Yablon SA; Barbano R; Brashear A;
J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):380-5. PubMed ID: 18977811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
